Approximate doubling of up-to-date status seen among Asian, Black, Hispanic, White patients, with corresponding decrease in CRC incidence, deaths.

Treatment with flumatinib plus ruxolitinib seems safe and effective in patients with primary myelofibrosis (MF) and chronic myelogenous leukemia (CML), according to a case study published in the ...

A retrospective analysis revealed that palliative care continues to be underutilized in patients with cervical cancer.

Researchers examined the addition of 3D total-body photography and sequential digital dermoscopy imaging to usual care on outcomes in patients at high risk for melanoma.

Researchers conducted a cohort study to assess the risks for azoospermia and prostate cancer among men with female relatives who have primary ovarian insufficiency.

The Food and Drug Administration (FDA) has approved the combination of nivolumab (Opdivo ®) plus ipilimumab (Yervoy ® ), both from Bristol Myers Squibb Company, as an option for first-line therapy for ...

Investigators studied cancer incidence, survival outcomes, and graft function among a multicenter cohort of kidney transplant recipients.

Patients with MSI-H mCRC had a higher probability of survival with first-line ICI therapy than with chemotherapy, but second-line or later ICIs did not confer the same benefit.

Researchers evaluated opioid prescribing trends by provider type for emergency department visits at noninstitutional and short-stay hospitals from 2019 to 2021.

HealthDay News — Exercise and rehabilitation services for patients with breast cancer through a clinical workflow algorithm called CORE (Comprehensive Oncology Rehabilitation and Exercise) is feasible ...

Overall survival after HCT for high-risk features in patients with SDS was superior to OS for HCT for MDS/AML, particularly ...

A novel assessment tool builds a bridge between nursing and finance that translates to improved nurse-to-patient ratios and ...